| 2VX3 |
2.4 |
Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A |
| 2WO6 |
2.5 |
Human Dual-Specificity Tyrosine-Phosphorylation-Regulated Kinase 1A in complex with a consensus substrate peptide |
| 3ANQ |
2.6 |
human DYRK1A/inhibitor complex |
| 3ANR |
2.6 |
human DYRK1A/harmine complex |
| 4AZE |
3.15 |
Human DYRK1A in complex with Leucettine L41 |
| 4MQ1 |
2.35 |
The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor |
| 4MQ2 |
2.8 |
The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor |
| 4NCT |
2.597 |
Human DYRK1A in complex with PKC412 |
| 4YLJ |
2.58 |
Crystal structure of DYRK1A in complex with 10-Iodo-substituted 11H-indolo[3,2-c]quinoline-6-carboxylic acid inhibitor 5j |
| 4YLK |
1.4 |
Crystal structure of DYRK1A in complex with 10-Chloro-substituted 11H-indolo[3,2-c]quinolone-6-carboxylic acid inhibitor 5s |
| 4YLL |
1.4 |
Crystal structure of DYRK1AA in complex with 10-Bromo-substituted 11H-indolo[3,2-c]quinolone-6-carboxylic acid inhibitor 5t |
| 4YU2 |
2.9 |
Crystal structure of DYRK1A with harmine-derivatized AnnH-75 inhibitor |
| 5A3X |
2.26 |
DYRK1A in complex with hydroxy benzothiazole fragment |
| 5A4E |
2.68 |
DYRK1A in complex with methoxy benzothiazole fragment |
| 5A4L |
2.73 |
DYRK1A IN COMPLEX WITH FLUORO BENZOTHIAZOLE FRAGMENT |
| 5A4Q |
2.37 |
DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT |
| 5A4T |
2.15 |
DYRK1A IN COMPLEX WITH NITRILE BENZOTHIAZOLE FRAGMENT |
| 5A54 |
2.63 |
DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT |
| 5AIK |
2.7 |
Human DYRK1A in complex with LDN-211898 |
| 6A1F |
1.5 |
Crystal structure of human DYRK1A in complex with compound 14 |
| 6A1G |
2.15 |
Crystal structure of human DYRK1A in complex with compound 32 |
| 6EIF |
2.22 |
DYRK1A in complex with XMD7-117 |
| 6EIJ |
2.42 |
DYRK1A in complex with HG-8-60-1 |
| 6EIL |
2.465 |
DYRK1A in complex with XMD8-49 |
| 6EIP |
2.56 |
DYRK1A in complex with XMD8-62e |
| 6EIQ |
2.3 |
DYRK1A in complex with XMD14-124 |
| 6EIR |
2.4 |
DYRK1A in complex with XMD15-27-2 |
| 6EIS |
2.36 |
DYRK1A in complex with JWC-055 |
| 6EIV |
2.68 |
DYRK1A in complex with JWD-065 |
| 6EJ4 |
2.88 |
DYRK1A in complex with XMD7-112 |
| 6LN1 |
2.699 |
A natural inhibitor of DYRK1A for treatment of diabetes mellitus |
| 6QU2 |
2.9 |
Crystal structure of DYRK1A complexed with FC162 inhibitor |
| 6S11 |
2.445 |
Crystal Structure of DYRK1A with small molecule inhibitor |
| 6S14 |
1.05 |
Crystal Structure of DYRK1A with small molecule inhibitor |
| 6S17 |
1.1 |
Crystal Structure of DYRK1A with small molecule inhibitor |
| 6S1B |
1.3 |
Crystal Structure of DYRK1A with small molecule inhibitor |
| 6S1H |
1.05 |
Crystal Structure of DYRK1A with small molecule inhibitor |
| 6S1I |
2.38 |
Crystal Structure of DYRK1A with small molecule inhibitor |
| 6S1J |
1.408 |
Crystal Structure of DYRK1A with small molecule inhibitor |
| 6T6A |
2.8 |
Crystal structure of DYRK1A complexed with KuFal319 (compound 11) |
| 6UIP |
3.7 |
DYRK1A Kinase Domain in Complex with a 6-azaindole Derivative, GNF2133. |
| 6UWY |
2.95 |
DYRK1A bound to a harmine derivative |
| 6YF8 |
3.198 |
DYRK1A with PST001 |
| 7A4O |
1.9 |
Structure of DYRK1A in complex with AMPNP |
| 7A4R |
1.8 |
Structure of DYRK1A in complex with compound 1 |
| 7A4S |
3.1 |
Structure of DYRK1A in complex with compound 2 |
| 7A4W |
2.7 |
Structure of DYRK1A in complex with compound 3 |
| 7A4Z |
1.9 |
Structure of DYRK1A in complex with compound 4 |
| 7A51 |
1.9 |
Structure of DYRK1A in complex with compound 5 |
| 7A52 |
2.1 |
Structure of DYRK1A in complex with compound 6 |
| 7A53 |
2.2 |
Structure of DYRK1A in complex with compound 7 |
| 7A55 |
2.2 |
Structure of DYRK1A in complex with compound 8 |
| 7A5B |
2.6 |
Structure of DYRK1A in complex with complex 10 |
| 7A5D |
1.8 |
Structure of DYRK1A in complex with compound 16 |
| 7A5L |
2.1 |
tructure of DYRK1A in complex with compound 24 |
| 7A5N |
2.3 |
Structure of DYRK1A in complex with compound 34 |
| 7AJ2 |
2.1 |
Structure of DYRK1A in complex with compound 3 |
| 7AJ4 |
2.0 |
Structure of DYRK1A in complex with compound 5 |
| 7AJ5 |
2.0 |
Structure of DYRK1A in complex with compound 10 |
| 7AJ7 |
2.9 |
Structure of DYRK1A in complex with compound 16 |
| 7AJ8 |
2.0 |
Structure of DYRK1A in complex with compound 25 |
| 7AJA |
2.2 |
Structure of DYRK1A in complex with compound 28 |
| 7AJM |
2.4 |
Structure of DYRK1A in complex with compound 32 |
| 7AJS |
2.15 |
Structure of DYRK1A in complex with compound 33 |
| 7AJV |
2.1 |
Structure of DYRK1A in complex with compound 38 |
| 7AJW |
2.8 |
Structure of DYRK1A in complex with compound 46 |
| 7AJY |
2.2 |
Structure of DYRK1A in complex with compound 51 |
| 7AK2 |
2.1 |
Structure of DYRK1A in complex with compound 53 |
| 7AKA |
1.9 |
Structure of DYRK1A in complex with compound 54 |
| 7AKB |
2.8 |
Structure of DYRK1A in complex with compound 56 |
| 7AKE |
2.3 |
Structure of DYRK1A in complex with compound 58 |
| 7AKL |
2.0 |
Structure of DYRK1A in complex with compound 50 |
| 7FHS |
2.42 |
Crystal structure of DYRK1A in complex with RD0392 |
| 7FHT |
2.68 |
Crystal structure of DYRK1A in complex with RD0448 |
| 7O7K |
1.82 |
Crystal structure of the human DYRK1A kinase domain bound to abemaciclib |
| 7OY6 |
2.38 |
Crystal structure of human DYRK1A in complex with ARN25068 |
| 7Z5N |
2.77 |
Crystal structure of DYRK1A in complex with CX-4945 |
| 7ZH8 |
2.3 |
DYRK1a in Complex with a Bromo-Triazolo-Pyridine |
